Skip to main content

Advertisement

Log in

Patient preferences and National Health Service costs: a cost-consequences analysis of cancer genetic services

  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

The study has three aims; firstly to establish if, having been informed of their risk status and that gene testing is inappropriate for them, low and moderate risk patients have misunderstood or failed to grasp this and want a test that is inappropriate for them. Secondly, to elicit patients’ willingness to pay for cancer genetic services. Thirdly, to ascertain the aspects of cancer genetics services that are important to high risk patients and present service configurations prioritised in terms of preferences accompanied by their costs (cost-consequences analysis). Patient preferences were gathered from 120 patients returning a self-administered discrete choice questionnaire issued post genetic risk assessment. Patients at low and moderate risk of developing breast cancer desired inappropriate testing. Patients at high, moderate and low risk of developing genetic cancer were willing to pay up to £3,000 for genetic serviced, which exceeds the current estimated cost of providing testing and counselling. Counselling by a genetics associate accompanied by favourable levels of other attributes provided high utility and substantial cost savings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

CGSW:

Cancer Genetics Service in Wales

DCM:

Discrete choice modelling

FAP or FAPC:

Familial adenomatous polyposis coli

GP:

General practitioner

HNPCC:

Hereditary nonpolyposis colorectal cancer

NHS:

National Health Service

References

  1. Lynch HT, Albano WA, Danes BS et al (1984) Genetic predisposition to breast cancer. Cancer 3:612–622. doi :10.1002/1097-0142(19840201)53:3+<M;612::AID-CNCR2820531306>3.0.CO;2-5

    Article  Google Scholar 

  2. Landis SH, Murray T, Bolden S et al (1999) Cancer statistics. CA Cancer J Clin 49:8–31. doi:10.3322/canjclin.49.1.8

    Article  CAS  PubMed  Google Scholar 

  3. Malanders S, Ridderheim M, Masback A et al (2004) One in 10 ovarian cancer patients carry germline BRCA1 or BRCA2 mutations. Results of a prospective study in Southern Sweden. Eur J Cancer 40(3):422–428. doi:10.1016/j.ejca.2003.09.016

    Article  CAS  Google Scholar 

  4. Risch HA, McLaughlin JR, Cole DEC et al (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in population series of 649 women with ovarian cancer. Am J Hum Genet 68:700–711. doi:10.1086/318787

    Article  CAS  PubMed  Google Scholar 

  5. Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71. doi:10.1126/science.7545954

    Article  CAS  PubMed  Google Scholar 

  6. Wooster R, Bignell G, Lancaster J et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789–792. doi:10.1038/378789a0

    Article  CAS  PubMed  Google Scholar 

  7. Aaltonen LA, Salovaara R, Kristo P et al (1989) Incidence of hereditary nonpolyposis cancer and the feasibility of molecular screening for the disease. N Engl J Med 338(21):1481–1487. doi:10.1056/NEJM199805213382101

    Article  Google Scholar 

  8. Soravia C, Bapat B, Cohen Z (1997) Familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC): a review of clinical, genetic and therapeutic aspects. Schweiz Med Wochenschr 127:682–690

    CAS  PubMed  Google Scholar 

  9. Griffith GL, Edwards RT, Gray J (2004) Cancer genetics services: a review of the economic evidence and issues. Br J Cancer 90(9):1697–1703

    CAS  PubMed  Google Scholar 

  10. National Institute for Health Clinical Excellence (2006) The Nice guideline (41). Familial breast cancer: the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. National Institute for Health and Clinical Excellence, London

    Google Scholar 

  11. Torrance N, Mollison J, Wordsworth S et al (2006) Genetic nurse counsellors can be an acceptable and cost-effective alternative to clinical geneticists for breast cancer risk genetic counselling. Evidence from two parallel randomised controlled equivalence trials. Br J Cancer 95(4):435–444. doi:10.1038/sj.bjc.6603248

    Article  CAS  PubMed  Google Scholar 

  12. Wilson B, Ryan M, Haites N (1999) Assessing user preferences for, and costs of, genetic counselling for familial cancer risk in Scotland: a cost-utility analysis using conjoint analysis. Chief Scientist Office, Edinburgh

    Google Scholar 

  13. Ryan M, McIntosh E, Shackley P (1998) Using conjoint analysis to elicit the views of health service users: an application to the patient health card. Health Expect 1:117–129. doi:10.1046/j.1369-6513.1998.00024.x

    Article  PubMed  Google Scholar 

  14. Ryan M (1996) Using consumer preferences in health care decision making. The application of conjoint analysis. Office of Health Economics, London

    Google Scholar 

  15. Wonderling D, Hopwood P, Cull A et al (2001) A descriptive study of UK cancer genetic services: an emerging clinical response to the new genetics. Br J Cancer 85(2):166–170. doi:10.1054/bjoc.2001.1893

    Article  CAS  PubMed  Google Scholar 

  16. Brain K, Gray J, Norman P et al (2000) Why do women attend familial breast cancer clinics? J Med Genet 37:1–5. doi:10.1136/jmg.37.3.197

    Article  Google Scholar 

  17. Turner J, France BW, Wilcinson C et al (2002) All Wales cancer genetics service: final report November 2002. Department of General practice, University of Wales College of Medicine, Wrexham

  18. Farrar S, Ryan M, Ross D et al (1997) Prioritisation of clinical service developments in a teaching hospital: an application of conjoint analysis. University of Aberdeen, Aberdeen

    Google Scholar 

  19. Parker BR, Srinivasan V (1976) A consumer preference approach to the planning of rural primary health care facilities. Oper Res 24(5):991–1025

    Article  Google Scholar 

  20. Louviere JJ, Hensher DA, Swait JD (2000) Stated choice methods: analysis and application. Cambridge University Press, Cambridge

    Google Scholar 

  21. Bradley M (1991) Users manual for the speed version 2.1 stated preference experiment editor and designer. Hague Consulting Group, The Hague

    Google Scholar 

  22. Greene WH (1998) Limdep version 7.0. Econometric software, Inc., New York

    Google Scholar 

  23. Viney R, Lancsar E, Louviere J (2002) Discrete choice experiments to measure consumer preference for health and health care. Expert Rev Pharmacoeconomics Outcomes Res 2(4):319–326. doi:10.1586/14737167.2.4.319

    Article  Google Scholar 

  24. Bech M, Gyrd-Hansen D (2005) Effects coding in discrete choice experiments. Health Econ 14(S1):S41–S57. doi:10.1002/hec.984

    Article  PubMed  Google Scholar 

  25. Griffith GL, Edwards RT, Gray J et al (2005) A micro costing of NHS cancer genetic services. Br J Cancer 92(1):60–71. doi:10.1038/sj.bjc.6602270

    Article  CAS  PubMed  Google Scholar 

  26. Office for National Statistics (2003) Census 2001. Office for National Statistics. http://www.statistics.gov.uk/census2002/profiles/printv/w-A.asp

  27. Rose D, O’Reilly K (1998) The ESRC review of government social classifications. Office for National Statistics & Economic and Social Research Council, London & Swindon

    Google Scholar 

  28. San Miguel F, Ryan M, Amaya-Amaya M (2005) Irrational stated preferences: a quantitative and qualitative investigation. Health Econ 14:307–322. doi:10.1002/hec.912

    Article  Google Scholar 

  29. Verhoef CG, Maas A, Stalpers LJA et al (1991) The feasibility of additive conjoint measurement in measuring utilities in breast cancer patients. Health Policy 17:39–50. doi:10.1016/0168-8510(91)90116-F

    Article  Google Scholar 

  30. Hanson K, McPake B, Nakamba P et al (2005) Preference for hospital quality in Zambia: results from a discrete choice experiment. Health Econ 14:687–701. doi:10.1002/hec.959

    Article  PubMed  Google Scholar 

  31. McIntosh E, Ryan M (2002) Using discrete choice experiments to derive welfare estimates for the provision of elective surgery: implications of discontinuous preferences. J Econ Psychol 23:367–382. doi:10.1016/S0167-4870(02)00081-8

    Article  Google Scholar 

  32. Ratcliffe J, Buxton M (1999) Patient preferences regarding the process and outcomes of life-saving technology. Int J Technol Assess Health Care 15(2):340–351

    CAS  PubMed  Google Scholar 

  33. Hall J, Kenny P, King M et al (2002) Using stated preference discrete choice modelling to evaluate the introduction of varicella vaccination. Health Econ 11:457–465. doi:10.1002/hec.694

    Article  PubMed  Google Scholar 

  34. Lancsar E, Savage E (2004) Deriving welfare measures from discrete choice experiments: a response to Ryan and Santos Silva. Health Econ 13:919–924. doi:10.1002/hec.885

    Article  Google Scholar 

  35. Bryan S, Buxton M, Sheldon R et al (1998) Magnetic resonance imaging for the investigation of knee injuries: a discrete choice conjoint analysis exercise. Health Econ 7:595–603. doi :10.1002/(SICI)1099-1050(1998110)7:7<595::AID-HEC381>3.0.CO;2-E

    Article  CAS  PubMed  Google Scholar 

  36. Bryan S, Dolan P (2004) Discrete choice experiments in health economics. Eur J Health Econ 5:199–202. doi:10.1007/s10198-004-0241-6

    Article  PubMed  Google Scholar 

  37. Scott A (2001) Eliciting GPs’ preferences for pecuniary and non-pecuniary job characteristics. J Health Econ 20:329–347. doi:10.1016/S0167-6296(00)00083-7

    Article  CAS  PubMed  Google Scholar 

  38. Steel M, Smyth E, Vasen H et al (1999) Ethical, social and economic issues in familial breast cancer: a compilation of views from the E.C. Biomed II demonstration project. Dis Markers 15(1–3):125–131

    CAS  PubMed  Google Scholar 

  39. Harper PS, Clarke AJ (1997) Genetics and society in clinical practice. Bios Scientific publishers, Oxford

    Google Scholar 

  40. Advisory Committee on Genetics Testing (1998) Genetic testing for late onset disorders (Harper report). Health Department of the United Kingdom, London

    Google Scholar 

  41. Genetics Research Advisory Group (1995) A second report to the NHS Central Research and Development Committee on the new genetics. Department of Health, HMSO, London

    Google Scholar 

  42. Royal College of Physicians (1991) Clinical genetic services in 1990 and beyond. Royal College of Physicians, London

    Google Scholar 

  43. Griffith GL (2008) Patient preferences in the delivery of cancer genetic services. Bangor University, Bangor

    Google Scholar 

  44. Monroe KB (1971) Psychophysics of price: a reappraisal. J Mark Res 8:248–251. doi:10.2307/3149772

    Article  Google Scholar 

  45. Dawes R, Corrigan B (1974) Linear models in decision making. Psychol Bull 81:95–106. doi:10.1037/h0037613

    Article  Google Scholar 

  46. Clarke A, Parsons E, Williams A (1996) Outcome and process in genetic counselling. Clin Genet 50:462–469

    Article  CAS  PubMed  Google Scholar 

  47. Hundley V, Ryan M (2004) Are women’s expectations and preferences for intrapartum care affected by the model of care on offer? BJOG 111:550–560. doi:10.1111/j.1471-0528.2004.00152.x

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to all the patients and staff of the Cancer Genetics Service in Wales that participated in this research. We also wish to thank the anonymous reviewers for their valuable comments.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gethin L. Griffith.

Electronic supplementary material

Below is the link to the electronic supplementary material.

MOESM1 [] (DOCX 152 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Griffith, G.L., Edwards, R.T., Williams, J.M.G. et al. Patient preferences and National Health Service costs: a cost-consequences analysis of cancer genetic services. Familial Cancer 8, 265–275 (2009). https://doi.org/10.1007/s10689-008-9217-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-008-9217-5

Keywords

Navigation